Manufacturing
-
Bio4C ProcessPad™ Product Overview
5/19/2020
Introducing Bio4C ProcessPad™ Software, part of the BioContinuum™ Platform.
-
Saudi Arabia Government Leaders Discuss Agile Manufacturing Beyond Borders
10/23/2022
Learn how government leaders in Saudi Arabia planned for biopharma resilience beyond borders and used agile manufacturing to prepare for the unknown.
-
A CDMO Perspective: Bioprocess Automation And Data Management
11/5/2025
Watch this video to understand data management and process automation challenges across single-use bioprocessing applications from a CDMO leader, Paul Jorjorian, VP and GM of Pharma Services at Thermo Fisher Scientific.
-
Elutriation And Washing In One System
6/21/2022
This elutriation and wash system can be used to initiate a wide number of cell therapy manufacturing processes such as CAR-T, dendritic cells, TIL, and IPSC-derived therapy.
-
Small-Scale Oligonucleotide Synthesizer That Supports Scale Up
2/16/2023
Learn about a small oligonucleotide synthesizer with big impact that features a user-friendly interface, compact footprint, and more. This small scale system is user friendly and supports scale up.
-
Freezing Studies For Single-Use Solutions
5/17/2024
Learn about the four common types of cryogenic studies for advanced therapies: controlled-rate, long-term, therapy containment/protection, and transportation.
-
DynaDrive S.U.B. Video Series
4/1/2026
Explore DynaDrive Single-Use Bioreactors through expert videos covering reactor design, mixing performance, sparge technology, and scalable workflows from bench-scale to commercial production.
-
HyPerforma 5:1 Single-Use Bioreactor (S.U.B.) Setup And Installation Part 2
5/7/2020
This video is part 2 of 3 videos that cover setup and installation topics related to the HyPerforma 5:1 Single-Use Bioreactor, or S.U.B. In this video we will cover initial BioProcess Container, or BPC, loading, drive shaft insertion, final installation steps.
-
Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond
12/17/2024
In this executive roundtable discussion, Bioprocess Online editor Tyler Menichiello is joined by CEO, co-founder, and president of Ossium Health, Kevin Caldwell, CSO of FibroBiologics, Hamid Khoja, Ph.D., and president and acting CEO of Triumvira Immunologics, Rob Williamson. The panelists share their predictions and thoughts on the industry’s direction heading into 2025. They cover manufacturing trends (noting opportunities for improvements in cell therapy manufacturing), AI adoption, regulatory concerns, and the potentially challenging funding environment ahead.
-
QC Sampling Post-Thaw And Scaling Up Automated Processes For iPSCs
4/15/2025
During this portion of our Cell & Gene Live, Optimizing Storage Solutions for iPSCs, expert panelists, Pratik Jaluria, Ph.D., SVP Technical Development Strategy at BlueRock Therapeutics, Bruno Marques, Ph.D. VP, Process and Product Development at Century Therapeutics, and Kate Rochlin, Ph.D., COO at IN8bio continue the discussion on post-thaw processing, focusing on QC sampling and the challenges of scaling up automated thawing.